Protocol EP0087: A Multicenter, Open-Label, Randomized, Parallel-Group, Active-Controlled Study to Assess the Efficacy and Safety of Brivaracetam Administered Intravenously as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

Project: Research project

Project Details

Effective start/end date6/14/176/14/20


  • PRA Health Sciences (Protocol EP0087 // Protocol EP0087)
  • UCB Biopharma SPRL (Protocol EP0087 // Protocol EP0087)